Luxury beauty growth shows no signs of slowing, and L’Oreal markets some heavy hitters in the luxury tier. But L’Oreal Paris, Maybelline and other big names within the firm’s Consumer division also are having a superb year, with one noted exception.
Amazon’s June launch of an indie beauty shop speaks volumes about the opportunity of late for charismatic new brands, but L’Oreal SA’s latest financial results are a bright sign that big cosmetics brands still have plenty of room to grow.
L’Oreal’s sales increased 6.8% like-for-like over the first nine months of fiscal 2018, reaching roughly €19.9bn ($22.7bn), according to the...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
